Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-06-12
2007-06-12
Wilson, James O. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S253010, C514S253110, C544S360000, C544S363000, C544S364000
Reexamination Certificate
active
10440011
ABSTRACT:
Compounds of the general formula (I):wherein R1, R2, R3and R4are as described in the specification.Further included are pharmaceutical compositions comprising the compounds, processes for their preparation, as well as the use of the compounds for the preparation of a medicament which particularly acts on the central nervous system, particularly for use as anti-obesity agents.
REFERENCES:
patent: 4078063 (1978-03-01), Lumma, Jr. et al.
patent: 6498184 (2002-12-01), Berendsen
patent: 0 370 560 (1990-05-01), None
patent: 0 580 465 (1994-01-01), None
patent: 1 213 017 (2002-06-01), None
patent: WO 94/03430 (1994-02-01), None
patent: WO 98/33504 (1998-08-01), None
patent: WO 01/41701 (2001-06-01), None
patent: WO 01/41701 (2001-06-01), None
Gaster et al. Annual Reports in Medicinal Chemistry, vol. 33, p. 21-30 (1998).
Isaac et al. Bioorganic & Medicinal Chemistry letters, vol. 10, pp. 919-921 (2000).
Nitsch et al. J. Biol. Chem. vol. 271, p. 4188-4194 (1996).
Francois Jenck et al., “Antiaversive effects of 5HT2Creceptor agonists and fluoxetine in a model of panic-like anxiety in rats”,European Neuropsychopharmacology, vol. 8, Issue 3, pp. 161-168 (Aug. 1, 1998).
R.H.P. Porter et al., “Functional characterization of agonists at recombinant human 5-HT2A, 5-HT2Band 5-HT2Creceptors in CHO-K1 cells”,British Journal of Pharmacology, vol. 128, pp. 13-20 (1999).
Andersson, “Pharmacology of penile erection.”Pharmacol. Rev., 53:417-450 (2001).
Andersson, “Treatment of the overactive bladder: possible central nervous system drug targets.”,Urology, 59(Suppl 5A):18-24 (2002).
Applegate et al., “Global increases in seizure susceptibility in mice lacking 5-HT2C receptors: A behavioural analysis.”,Exp. Neurol., 154:522-530 (1998).
Arjona et al., “Effect of a 5-HT(2C) serotonin agonist, dexnorfenfluramine, on amyloid precursor protein metabolism in guinea pigs.”,Brain Res., 951:135-140 (2002).
Berendsen, “The role of serotonin in hot flushes”,Maturitas, 36:155-164 (2000).
Bishop et al., “New 5-HT2Creceptor agonists”,Expert Opin. Ther. Patents, 13(11):1691-1705 (2003).
Chojnacka-Wojcik et al., “Involvement of 5-HT2C receptors in the m-CPP-induced antinociception in mice.”Pol J Pharmacol., 46(5):423-428 (1994).
Cryan et al., “Antidepressant-like behavioral effects mediated by 5-Hydroxytryptamine(2C) receptors.”J. Pharmacol Exp. Ther., 295(3):1120-1126 (2000).
de Groat et al., “Influence of central serotoneric mechanisms on lower urinary tract function.”Urology, 59(Suppl. 5A):30-36 (2002).
Dhonnchadha, et al., “Anxiolytic-like effects of 5-HT2 ligands on three mouse models of anxiety”,Behavioural Brain Research, 140(1-2):203-214 (2003).
Goodman and Gilman's, The Pharmalogical basis of Therapeutics, 8thed., McGraw-Hill, Int. Ed. 1992, “Biotransformation of Drugs”, p. 13-15.
Grottick et al., “Activation of 5-HT(2C) receptors reduces the locomotor and rewarding effects of nicotine.”Psychopharmacology (Berl), 157(3):292-8 (2001).
Grottick et al., “Studies to investigate the role of 5-HT(2C) receptors on cocaine- and food-maintained behavior.”J Pharmacol Exp Ther., 295(3):1183-91 (2000).
Guarneri et al., “The effects of m-CPP on bladder voiding contractions in rats are mediated by the 5-HT2A/5-HT2C receptors.”,Neurourol. Urodyn., 15:316-317 (1996).
Heisler et al., “Epilepsy and obesity in serotonin 5-HT2C receptor mutant mice.”Ann NY Acad Sci, 861:74-78 (1998).
Isaac, “The 5-HT2C receptor as a potential therapeutic target for the design of antiobesity and antiepileptic drugs.”,Drugs Future, 26:383-393 (2001).
Kenakin, “Inverse, protean, and ligand-selective agonism: matters of receptor conformation,”The FASEB Journal, 15:598-611 (2001).
Millan et al., “5-HT2C receptors mediate penile erections in rats: actions of novel and selective agonists and antagonists.”,Eur. J. Pharamcol., 325:9-12 (1997).
Moreau et al., “5HT2C receptor agonists exhibit antidepressant-like properties in the anhedonia model of depression in rats.” Pharma Division, Preclinical CNS Research, F. Hoffmann-La Roche Ltd, Basel, Switz. European Neuropyschopharmacology (1996), 6(3):169-175. Coden:Eurne8 Issn: 0924-977X. Journal written in English. CAN 125:265667 AN 1996:491063 CAPLUS.
Nonogaki et al., “Leptin-independent hyperphagia and type 2 diabetes in mice with a mutated serotonin 5-HT2Creceptor gene”,Nature Medicine, 4(10):1152-1156 (1998).
Piesla et al., “Atypical antipsychotic-like effects of 5-HT2C agonists.”Schizophrenia Res., 49(1-2):95-95 Sp. Iss. SI Suppl. S, Apr. 15, 2001.
Pornerantz, “5-HTIA and 5-HTIC/D receptor agonists produce reciprocal effects on male sexual behavior of rhesus monkeys.”,Eur. J. Pharmacol., 243:227-234 (1993).
Porter, et al., “Functional characterization of agonists at recombinant human 5-HT2A, 5-HT2Band 5-HT2Creceptors in CHO-K1 cells”,British Journal of Pharmacology, 128:13-20 (1999).
Pranzatelli et al., “Identification of spinal 5-HT1C binding sites in the rat: characterization of [3H]mesulergine binding.”J. Pharmacol. Exp. Ther., 261:161-165 (1992).
Steers et al., “Effects of m-chlorophenylpiperazine on penile and bladder function in rats.”,Am. J. Physiol., 257:R1441-R1449 (1989).
Steers et al., “Effects of serotonergic agonists on micturition and sexual function in the rat.”Drug Dev. Res., 27:361-375 (1992).
Szele et al., “Effects of fenfluramine, m-chlorophenylpiperazine, and other serotonin-related agonists and antagonists on penile erections in nonhuman primates.”,Life Sci., 43:1297-1303 (1998).
Tecott et al., “Eating disorder and epilepsy in mice lacking 5-HT2C serotonin receptors.”Nature, 374:542-546 (1995).
Testa et al., “Effect of different 5-hydroxytryptamine receptor subtype antagonists on the micturition reflex in rats.”,BJU Int., 87:256-264 (2001).
Upton et al., “Studies on the role of 5-HT2C and 5-HT2B receptors in regulating generalized seizure threshold in rodents.”Eur. J. Pharmacol., 359:33-40 (1998).
Nilsson Björn M.
Ringberg Erik
Biovitrum AB
Fish & Richardson P.C.
Sackey Ebenezer
Wilson James O.
LandOfFree
Compounds and their use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds and their use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds and their use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3814716